Article Text
Editorial
Patients with Down syndrome and congenital heart disease: survival is improving, but challenges remain
Statistics from Altmetric.com
Footnotes
Contributors Both authors have contributed in drafting the manuscript.
Competing interests KD has received unrestricted education grants and has acted as a consultant for Actelion, GSK, Pfizer and Bayer.
Provenance and peer review Commissioned; internally peer reviewed.